(RS)-etodolac
Etodolac is a nonsteroidal anti-inflammatory drug (NSAID).
Research
4 papers- Liquid chromatographic enantioseparation of (RS)-etodolac using (S)-levofloxacin and determination of absolute configuration of the diastereomeric derivatives.Biomedical chromatography : BMC · 2019
- A novel approach for enantioseparation as applied to (RS)-etodolac from pharmaceutical formulations: LC MS and density functional theory support for confirmation of diastereomers so separated.Biomedical chromatography : BMC · 2015
- HPLC enantioseparation of racemic bupropion, baclofen and etodolac: modification of conventional ligand exchange approach by pre-column formation of chiral ligand exchange complexes.Biomedical chromatography : BMC · 2016
- Ligand Exchange Thin Layer Chromatographic Enantioresolution of (RS)-Ketorolac and (RS)-Etodolac and Recovery of Native Enantiomers.Journal of chromatographic science · 2019
via PubMed
Article
6 sectionsContents
- Medical uses
- Interactions
- Pregnancy and nursing
- Brand names
- References
- External links
Etodolac is a nonsteroidal anti-inflammatory drug (NSAID).
It was patented in 1971 and approved for medical use in 1985. It was approved in the U.S. in 1991.